These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35041984)
1. The combination of photodynamic therapy and ultrapulse carbon dioxide laser for facial angiofibromas in tuberous sclerosis complex: A case report. Wang B; Yao Y; Huang X; Zhang L; Peng D; Zhang G Photodiagnosis Photodyn Ther; 2022 Mar; 37():102725. PubMed ID: 35041984 [TBL] [Abstract][Full Text] [Related]
2. Treatment of nodular facial angiofibromas in tuberous sclerosis, using ultrapulse carbon dioxide laser. Biondo G; Greco S; Mavilia L; Mercuri SR Clin Exp Dermatol; 2014 Aug; 39(6):738-40. PubMed ID: 24890518 [TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy in a patient with facial angiofibromas due to tuberous sclerosis complex. Shi M; He S; Chen P; Li Q; Zhu M; Guo J; Jiang L; Wang Q; Peng X; Li S; Li C; Zeng K Photodiagnosis Photodyn Ther; 2019 Dec; 28():183-185. PubMed ID: 31398516 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of Angiofibromas in a Tuberous Sclerosis Patient Using Topical Timolol 0.5% Gel. Krakowski AC; Nguyen TA Pediatrics; 2015 Sep; 136(3):e709-13. PubMed ID: 26304829 [TBL] [Abstract][Full Text] [Related]
5. Facial angiofibromas treated by rapamycin 0.05% ointment and a combined laser therapy. Negosanti F; Tengattini V; Gurioli C; Neri I J Cosmet Dermatol; 2018 Oct; 17(5):762-765. PubMed ID: 30123982 [TBL] [Abstract][Full Text] [Related]
6. The Efficacy of Everolimus for Facial Angiofibromas in Tuberous Sclerosis Complex Patients Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma. Wei CC; Hsiao YP; Gau SY; Wu YT; Wu CT; Wu MH; Tsai JD Dermatology; 2021; 237(3):444-449. PubMed ID: 33032292 [TBL] [Abstract][Full Text] [Related]
7. Management of facial angiofibromas in tuberous sclerosis: use of the carbon dioxide laser. Bellack GS; Shapshay SM Otolaryngol Head Neck Surg; 1986 Jan; 94(1):37-40. PubMed ID: 3005944 [TBL] [Abstract][Full Text] [Related]
8. Targeted topical and combination laser surgery for the treatment of angiofibromas. Bae-Harboe YS; Geronemus RG Lasers Surg Med; 2013 Nov; 45(9):555-7. PubMed ID: 24136238 [TBL] [Abstract][Full Text] [Related]
9. Treatment of facial angiofibromas with topical application of oral rapamycin solution (1mgmL(-1) ) in two patients with tuberous sclerosis. Mutizwa MM; Berk DR; Anadkat MJ Br J Dermatol; 2011 Oct; 165(4):922-3. PubMed ID: 21692776 [No Abstract] [Full Text] [Related]
10. New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis. Weiss ET; Geronemus RG Lasers Surg Med; 2010 Jul; 42(5):357-60. PubMed ID: 20583249 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial. Koenig MK; Bell CS; Hebert AA; Roberson J; Samuels JA; Slopis JM; Tate P; Northrup H; JAMA Dermatol; 2018 Jul; 154(7):773-780. PubMed ID: 29800048 [TBL] [Abstract][Full Text] [Related]
12. Treatment of angiofibromas of tuberous sclerosis with 5-aminolevulinic acid blue light photodynamic therapy followed by immediate pulsed dye laser. Weinberger CH; Endrizzi B; Hook KP; Lee PK Dermatol Surg; 2009 Nov; 35(11):1849-51. PubMed ID: 19682000 [No Abstract] [Full Text] [Related]
13. A novel topical rapamycin cream for the treatment of facial angiofibromas in tuberous sclerosis complex. Wheless JW; Almoazen H J Child Neurol; 2013 Jul; 28(7):933-6. PubMed ID: 23680945 [TBL] [Abstract][Full Text] [Related]
14. Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: a pilot study of four patients. Foster RS; Bint LJ; Halbert AR Australas J Dermatol; 2012 Feb; 53(1):52-6. PubMed ID: 22309333 [TBL] [Abstract][Full Text] [Related]
15. Our experience of carbon dioxide laser ablation of angiofibromas: Case series and literature review. Ali FR; Mallipeddi R; Craythorne EE; Sheth N; Al-Niaimi F J Cosmet Laser Ther; 2016 Nov; 18(7):372-375. PubMed ID: 27331628 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex : A Randomized Clinical Trial. Wataya-Kaneda M; Nakamura A; Tanaka M; Hayashi M; Matsumoto S; Yamamoto K; Katayama I JAMA Dermatol; 2017 Jan; 153(1):39-48. PubMed ID: 27837201 [TBL] [Abstract][Full Text] [Related]
17. Treatment of angiofibromas in tuberous sclerosis complex: the effect of topical rapamycin and concomitant laser therapy. Park J; Yun SK; Cho YS; Song KH; Kim HU Dermatology; 2014; 228(1):37-41. PubMed ID: 24401865 [TBL] [Abstract][Full Text] [Related]
18. Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial. Wataya-Kaneda M; Ohno Y; Fujita Y; Yokozeki H; Niizeki H; Ogai M; Fukai K; Nagai H; Yoshida Y; Hamada I; Hio T; Shimizu K; Murota H JAMA Dermatol; 2018 Jul; 154(7):781-788. PubMed ID: 29800026 [TBL] [Abstract][Full Text] [Related]
19. Tuberous Sclerosis Complex in 29 Children: Clinical and Genetic Analysis and Facial Angiofibroma Responses to Topical Sirolimus. Wang S; Liu Y; Wei J; Zhang J; Wang Z; Xu Z Pediatr Dermatol; 2017 Sep; 34(5):572-577. PubMed ID: 28771801 [TBL] [Abstract][Full Text] [Related]
20. A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin. Sigg N; Fouquet J; Morin D; Farges D; Vrignaud S; Martin L Ann Dermatol Venereol; 2023 Dec; 150(4):270-273. PubMed ID: 37821253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]